Where Leaders in Oncology UniteAgainst Lung Cancer||To Share Knowledge||To Exchange||To Debate||To Advance Care||To Fight Cancer||To Drive Progress||To Provide Insights
CME-certified
Expert-Driven Education & Insights
LATEST
ILCS 2025
WE Invite You To Joinexciting discussions||our annual meeting||us in Lausanne||leading experts
International Lung Cancer Summit '25
ADD THIS TO YOUR CALENDAR
Google Calendar (Online)
Outlook Calendar (Offline)-
Outlook On Microsoft Office 365 (Online) -
Outlook On The Web (Online) 
Apple Offline Calendar / iCal
When: 9:45 AM - 4:30 PM (CEST)
Following the success of the previous International Lung Cancer Summits (ILCS), we warmly invite you to the 7th edition, expertly chaired by the distinguished duo Solange Peters and Alfredo Addeo. This premier hybrid conference continues its tradition of excellence by highlighting the latest breakthroughs in lung cancer treatment. With a global lineup of renowned speakers from the USA, France, UK, Spain, Ireland, Italy, Australia, Singapore, and Switzerland, the ILCS provides a unique platform for professionals from clinics, universities, and research institutes to engage, network, and collaborate. By leveraging digital platforms, the summit fosters a dynamic environment for sharing insights and advancing lung cancer care.
LED BY GLOBAL EXPERTS
Marius Ilié
France
Antonio Passaro
Italy
Xiuning Le
USA
Andrea Filippi
Italy
Noemi Reguart
Spain
Tom John
Australia
Alessandra Curioni
Switzerland
Patrick Forde
Ireland
Stephanie Saw
Singapore
Thomas Newsom-Davis
United Kingdom
Rami Manochakian
USA
For sponsoring opportunities, please contact us at sponsoring@lungsummit.org
ADD THIS TO YOUR CALENDAR
- Google Calendar (Online)
- Outlook Calendar (Offline)
- Outlook On Microsoft Office 365 (Online)
- Outlook On The Web (Online)
- Apple Offline Calendar / iCal
When: 9:45 AM - 4:30 PM (CEST)
CHECK OUT OUR PROGRAM
26th September 2025
All times are in Central European Time
9.45
Welcome & Introduction by Chairs
Solange Peters & Alfredo Addeo
9.50
CUTTING-EDGE DIAGNOSTIC TECHNIQUES AND EMERGING BIOMARKERS
Marius Ilié (France)
10.10
TARGETING EGFR AND ALK IN NSCLC
Tom John (Australia)
10.35
OTHER ACTIONABLE GENOMIC ALTERATIONS – INCLUDING HER2 AND MET
Stephanie Saw (Singapore)
11.00
Open Discussion & Coffee Break
11.20
DEBATE: WHICH IS THE BETTER CHOICE IN EGFR+ METASTATIC NSCLC?
-
ARGUING IN FAVOR OF AMIVANTAMAB + LAZERTINIB
Xiuning Le (USA)
-
ARGUING IN FAVOR OF OSIMERTINIB + CHEMO
Tom Newsom-Davis (UK)
11.50
THE ADC REVOLUTION IN LUNG CANCER: NEW TARGETS, NEW OPPORTUNITIES
Noemà Reguart (Spain)
14.15
TAILORING IO IN RESECTABLE NSCLC: PERSONALIZED APPROACHES FOR IMPROVED OUTCOMES
Patrick Forde (Ireland)
14.45
THE ROLE IO ADDED TO CHEMORADIATION IN UNRESECTABLE STAGE III NSCLC
ANDREA R. FILIPPI (Italy)
15.10
Open Discussion & Coffee Break
15.30
LATEST OPTIONS FOR NON-ONCOGENE ADDICTED METASTATIC NSCLC IN FRONTLINE BEYOND ADCs
Alessandra Curioni (Switzerland)
15.50
RESHAPING OUR APPROACHES IN SCLC WITH THE LATEST ADVANCES IN LIMITED- AND EXTENSIVE-STAGE DISEASE
Rami Manochakian (USA)
16.20
Open Questions, Patient Cases & Guidelines
Panel Discussion With All
16.45
Closing Remarks by Chairs
Solange Peters & Alfredo Addeo
Sponsors of ILCS 2025
